Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $7.1M $9.7M $4.6M
Accounts Receivable $2.1M $307.0K $6.5M
Inventory $1.0M $461.0K $20.3M
Total Current Assets $95.1M $71.4M $35.1M
Property, Plant & Equipment $5.8M $5.9M $4.2M
Goodwill — $29.2M $29.2M
Intangible Assets (Excl. Goodwill) $6.1M $6.9M —
Total Assets $117.0M $91.9M $127.8M
Liabilities
Accounts Payable — — —
Total Current Liabilities $18.5M $19.5M $19.9M
Long-Term Debt $15.7M $18.4M —
Total Liabilities $35.0M $41.3M $39.1M
Stockholders' Equity
Retained Earnings $-73.7M $-80.7M $-232.0M
Total Stockholders' Equity $82.0M $50.6M $88.6M
← Newer Page 2 of 2 Older →